Back to top
more

Viemed Healthcare (VMD)

(Real Time Quote from BATS)

$8.09 USD

8.09
112,705

+0.03 (0.37%)

Updated Apr 24, 2024 03:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (152 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Viemed Healthcare, Inc. (VMD) Misses Q1 Earnings Estimates

by Zacks Equity Research

Viemed Healthcare, Inc. (VMD) delivered earnings and revenue surprises of -42.86% and 3.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Pediatrix (MD) Down 4.2% Despite Q1 Earnings & Revenue Beat

by Zacks Equity Research

Investors are likely concerned about Pediatrix's (MD) lower enrollment in commercial insurance programs, escalating practice salaries and benefits and net borrowings.

BellRing Brands Inc. (BRBR) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

BellRing Brands (BRBR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

LeMaitre (LMAT) delivered earnings and revenue surprises of 8% and 7.63%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Viemed Healthcare, Inc. (VMD) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Viemed Healthcare, Inc. (VMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Elevance Health (ELV) Beats on Q1 Earnings, Hikes Profit View

by Zacks Equity Research

Elevance Health's (ELV) first-quarter results reflect growing premiums stemming from rate increases.

UnitedHealth (UNH) Beats on Q1 Earnings, Ups EPS 2023 View

by Zacks Equity Research

Strong membership growth and consistent management of medical and operating costs aid UnitedHealth's (UNH) UnitedHealthcare unit in the first quarter.

Viemed Healthcare, Inc. (VMD) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Viemed Healthcare, Inc. (VMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Brookdale (BKD) Q1 Adjusted EBITDA to Beat View, Occupancy Up

by Zacks Equity Research

Brookdale Senior Living (BKD) witnesses 17 straight months of year-over-year increases in weighted average occupancy level.

Palo Alto Networks and RH have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Palo Alto Networks and RH are part of the Zacks Bull and Bear of the Day article.

Indrajit Bandyopadhyay headshot

3 Medical Product Stocks With Strong Potential to Gain in 2023

by Indrajit Bandyopadhyay

Here we discuss three medical instruments stocks, LNTH, RMTI and VMD, which are witnessing solid momentum in 2023. These stocks have the potential to continue their uptrend going forward.

Boston Scientific (BSX) Hits 52-Week High: What's Driving It?

by Zacks Equity Research

Boston Scientific (BSX) outperforms the industry and the S&P 500 due to several new acquisitions and the long-term growth prospects of the WATCHMAN device.

Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?

by Zacks Equity Research

Bruker Corporation (BRKR) outperforms the industry and the S&P 500 due to impressive quarterly results and segmental prospects.

UnitedHealth (UNH) Arm to Reduce Prior Authorization Time

by Zacks Equity Research

UnitedHealth's (UNH) UnitedHealthcare business to lower the use of prior authorization process or preauthorization by almost 20%.

Tenet Healthcare (THC) Jumps 14.9% YTD: More Growth Ahead?

by Zacks Equity Research

Tenet Healthcare's (THC) focus on boosting USPI's network is positioning the company for expedited growth.

Elevance (ELV) Arm to Bring Virtual-First Plans to Georgia

by Zacks Equity Research

The cocktail of virtual and in-person options from Elevance Health's (ELV) part of the Anthem family of brands is expected to enrich members' health experience.

Indrajit Bandyopadhyay headshot

3 Medical Device Stocks With Potential to Fight Recession Risk

by Indrajit Bandyopadhyay

Increasing interest rates, higher costs and rising unemployment paint an unfavorable picture with the risk of a recession looming large. Here we discuss three medical stocks that may be good bets even in a recession.

Recent Price Trend in Viemed Healthcare, Inc. (VMD) is Your Friend, Here's Why

by Zacks Equity Research

Viemed Healthcare, Inc. (VMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

The Joint (JYNT) to Enter Puerto Rico With New Franchise Deal

by Zacks Equity Research

The Puerto Rico deal with the Comerfords marks The Joint's (JYNT) first franchise deal outside the continental United States.

Humana (HUM) Rises 9.7% in a Year: More Room for Growth?

by Zacks Equity Research

Humana's (HUM) individual Medicare Advantage membership growth is likely to boost premium income.

Encompass Health's (EHC) 155th Hospital Opens in Wisconsin

by Zacks Equity Research

The Rehabilitation Hospital of Western Wisconsin is Encompass Health's (EHC) first location in the state.

UnitedHealth (UNH) Plan in Indiana to Offer Pathways Program

by Zacks Equity Research

UnitedHealth (UNH) expects the new Pathways for Aging program to serve around 100,000 people.

Brookdale Senior (BKD) February Weighted Average Occupancy Up

by Zacks Equity Research

Brookdale Senior Living (BKD) witnesses 16 straight months of year-over-year increases in weighted average occupancy level.

Viemed Healthcare, Inc. (VMD) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

Viemed Healthcare, Inc. (VMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Viemed Healthcare, Inc. (VMD) Lags Q1 Earnings Estimates

by Zacks Equity Research

Viemed Healthcare, Inc. (VMD) delivered earnings and revenue surprises of -33.33% and 1.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?